Shire Sues Mylan Over Intuniv Patents

Law360, New York (April 21, 2011, 2:01 PM EDT) -- Shire LLC filed a patent infringement suit against Mylan Pharmaceuticals Inc. on Wednesday in West Virginia federal court over the generic-drug maker’s bid to produce a version of attention deficit hyperactivity disorder drug Intuniv.

Shire claims that Mylan recently filed a request with the U.S. Food and Drug Administration to produce a generic version of Intuniv in 4-milligram tablets before the expiration of U.S. Patent Numbers 6,287,599 and 6,811,794, which cover the drug. Supernus Pharmaceuticals Inc., also a plaintiff in the case and a former subsidiary...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.